The Children's Hospital at Westmead - Gene Therapy Research Unit
Edit Page
Report
Scan day: 17 February 2014 UTC
13
Virus safety - good
Description: A joint initiative of The New Children's Hospital and the Children's Medical Research Institute is undertaking gene therapy clinical trials in Australia. Research projects include cancer immunotherapy, vector development, HIV infection, targeting gene delivery to specific tissue types.
Gene Therapy Research Unit - The Children's Hospital at Westmead A joint initiative of The Children's Hospital at Westmead and The ultimate aim of biomedical research is to improve human health, but its more immediate impact, beyond the accumulation of biological knowledge, is an increase in our capacity to diagnose disease. Therapeutic benefits follow, but significantly more slowly. Herein lies a potentially frustrating paradox. When biomedical knowledge is undergoing rapid growth (as it is at present) we can anticipate a widening of the gap between our capacity to diagnose and our capacity to treat disease. For this reason it is fundamentally important that increased effort be focused on realising the therapeutic potential of advances in biological knowledge. Such an effort demands that we explore entirely new therapeutic paradigms and surmount the formidable translational challenges inherent in taking new therapies from the laboratory bench to the patient bedside. Gene Therapy, or "the use of genes as medicine" is one such paradigm, with immense but largely unrealised potential.
Size: 1118 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Gene Therapy Research Unit - The Children's Hospital at Westmead |
| Keywords: | academies and institutes, children's hospitals, gene therapy, hospital units, research and development |
| Description: | A joint initiative of The Children's Hospital at Westmead and the Children's Medical Research Institute. This strategic partnership has allowed the development of a robust and successful scientific research and development program that is rapidly progressing from the laboratory bench to the patient bedside. |
| IP-address: | 203.34.41.162 |